Healey Don 4

What Happened
Don Healey, Chief Technology Officer of Adicet Bio, reported that 535 shares were disposed on 2026-01-24 at an effective price of $8.44 per share, for a total value of about $4,515. The Form 4 indicates this disposition is a company share-withholding to cover tax withholding in connection with the vesting of restricted stock units (RSUs), not an open-market sale by the reporting person.

Key Details

• Transaction date: 2026-01-24; reported on Form 4 filed 2026-01-27.
• Shares withheld/disposed: 535 shares at $8.44 each; total ~$4,515.
• Shares owned after transaction: not specified in the provided filing excerpt.
• Footnote F1: Shares were withheld by the issuer to satisfy tax withholding on RSU vesting and do not represent a sale by the reporting person.
• Footnote F2: Share counts reflect a 1-for-16 reverse stock split effected 2025-12-30.
• Filing timeliness: Form 4 was filed 1/27/2026 reporting the 1/24/2026 event; no late filing flag was indicated in the excerpt.

Context
Tax-withholding dispositions for vested RSUs are routine and typically do not signal insider sentiment because the company, not the insider, withholds shares to cover tax obligations. The transaction is coded as F (tax withholding/cashless net settlement) rather than a market sale (S).